Fierce Pharma
JULY 31, 2024
Four months after Bayer handed pink slips to 90 staffers at its U.S. headquarters in Whippany, New Jersey, the company is laying off 70 more workers at the site. | Four months after Bayer handed pink slips to 90 staffers at its U.S. headquarters in Whippany, New Jersey, the company is laying off 70 more at the site, according to a state Worker Adjustment and Retraining Notification.
Pharma IQ
JULY 31, 2024
Explore the challenges and strategic solutions involved in integrating AI into established legacy systems in the Pharma Industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JULY 31, 2024
On the heels of game-changing trial results presented at la | On the heels of game-changing trial results presented at last year's ASH meeting, J&J is introducing what it calls a "foundational frontline therapy" in multiple myeloma and at the same time expanding its already impressive presence in the field.
MedCity News
JULY 31, 2024
AIRNA’s therapy for alpha1 antitrypsin deficiency, or AATD, edits RNA to address the underlying cause of this rare inherited disease. Wave Life Sciences and Korro Bio are both further along in the development of RNA-editing therapies for AATD, but AIRNA claims its therapy could be best in class. The post Biotech Startup AIRNA Adds $60M to Advance RNA-Editing Therapy for Rare Protein Deficiency appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
JULY 31, 2024
The end of an era is nearing for Lundbeck. After a 17-year collaboration with Takeda on depression drug Trintellix, the Danish drugmaker is passing over its U.S. rights to its partner. | Lundbeck will collect only royalties on Takeda's U.S. sales of the partners' depression med as it reallocates resources to other growth drivers such as antipsychotic Rexulti.
MedCity News
JULY 31, 2024
At the INVEST Digital Health conference on September 18 at Pegasus Park in Dallas, cybersecurity will be part of the conversation. A panel will highlight how hospitals are dealing with the security threat such as HHS policies, staff training, and more. The post How Are Health Systems and Health Tech Addressing Cybersecurity? A Timely Panel Discussion at INVEST Digital Health appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
JULY 31, 2024
Vertex has filed for FDA approval of its non-opioid pain drug suzetrigine, starting the clock ticking on a review that should be completed early next year
Fierce Pharma
JULY 31, 2024
The whole respiratory syncytial virus (RSV) vaccine field took a beating when the Centers for Disease Control and Prevention’s (CDC's) immunization committee doled out a limited recommendation last | The whole RSV vaccine field took a beating when the CDC’s immunization committee doled out a limited recommendation last month. And it’s showing in GSK’s forecast for 2024, just as the company’s Shingrix disappointed.
MedCity News
JULY 31, 2024
It’s time for technology to deliver the tools that will help healthcare professionals respond to a mental health or substance misuse crisis with the same urgency we extend to patients experiencing a physical health emergency. The post 988 Turns Two: What’s Next for the Crisis Response Lifeline? appeared first on MedCity News.
Fierce Pharma
JULY 31, 2024
Even with new entrants edging into the crowded irritable bowel disease (IBD) market and potentially threatening Entyvio’s spot as the market leader, Takeda figures its product still has room to gro | With a new subcutaneous formulation for Entyvio, the Japanese drugmaker isn't worried about new entrants affecting its leading spot in the first-line IBD market over the long run.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
JULY 31, 2024
Patient advocacy group APIC has started a campaign to stop Novo Nordisk from following through on a plan to stop making insulin product Levemir
Fierce Pharma
JULY 31, 2024
Three-year data from a study of early Alzheimer’s disease (AD) patients on Eisai and Biogen’s Leqembi showed that longer-term use provi | Three-year data from a study of early Alzheimer’s disease patients on Eisai and Biogen’s Leqembi showed that longer-term use provides continued benefits without additional safety concerns.
pharmaphorum
JULY 31, 2024
GSK raises 2024 forecasts on a strong Q2 led by HIV and cancer drugs, but its shares weakened on litigation concerns and weaker vaccine expectations
Fierce Pharma
JULY 31, 2024
MELISSA CONNOLLY, Associate Principal, Strategy Consulting, IQVIAJESSICA MESERVEY, Senior Principal, Patient Engagement, IQVIA | Pharma often measures customer experiences rigorously, but PSPs lack this focus. IQVIA, with a top pharma company, created a framework to improve PSP evaluation.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
pharmaphorum
JULY 31, 2024
Eisai, Biogen report data showing benefit of Alzheimer's disease therapy Leqembi builds with time, with no increase in safety risk
MedCity News
JULY 31, 2024
Here is a selection of recent executive hires, retirements, promotions and layoffs occurring across the healthcare industry. The post Healthcare Moves: A Monthly Summary of Hires and Layoffs appeared first on MedCity News.
Pharmaceutical Commerce
JULY 31, 2024
The latest news for pharma industry insiders.
MedCity News
JULY 31, 2024
When we consider the value of NEMT services, it’s critical to start with how these services impact the individual. Transport providers are on the frontlines of helping to ensure equal access to care and prevent long-term health issues that may arise from missed appointments. The post The Crucial Role of Non-Emergency Medical Transportation Providers in Driving Health Equity appeared first on MedCity News.
PharmaTimes
JULY 31, 2024
Quantum-based technologies will explore infectious diseases, cancer and dementia
MedCity News
JULY 31, 2024
Story Health is now providing cardiovascular support to Zing Health’s members. They’ll get access to a care team that includes cardiologists, cardiac nurse practitioners, registered nurses and health coaches. The post Zing Health, Story Health Partner To Bring Cardiology Support to At-Risk Members appeared first on MedCity News.
PharmaVoice
JULY 31, 2024
The U.S. government will demand payment from Big Pharma to make up for dozens of drugs with prices that rose faster than the rate of inflation.
Pharmaceutical Technology
JULY 31, 2024
Pfizer has posted a 98% decrease in net income attributable to shareholders of $41m for Q2 2024, compared to $2.3bn in Q2 2023.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
PharmaTimes
JULY 31, 2024
The latest collaboration marks Apollo’s sixth agreement with a research institution
Pharmaceutical Technology
JULY 31, 2024
Gene therapy research is expensive. Biotechs invest millions of dollars in early research to develop therapies for conditions that might be rare. But when funds are limited and the market potential is dim, such programs are often abandoned by companies, leaving patients and investigators in a bind.
pharmaphorum
JULY 31, 2024
FibroGen has pulled the plug on its lead drug pamrevlumab after two failed trials in pancreatic cancer and immediately announced plans to shed three-quarters of its workforce.The San Francisco biotech confirmed that neither the PanCAN Precision Promise study in metastatic pancreatic cancer nor the LAPIS trial in patients with locally advanced, unresectable pancreatic cancer had shown an improvement in overall survival (OS) with the drug.
Pharmaceutical Technology
JULY 31, 2024
MSD has reported a net income on a GAAP basis of $5.4bn for Q2 2024 compared to the net loss of $5.9bn in the same quarter of 2023.
Integrity Solutions
JULY 31, 2024
Money and incentives matter, but they are only part of the sales retention story. The pace of transformation and continual shifting conditions in the business environment over the past few years have made us all feel like we’re on a roller coaster ride — and you can be sure there will be many more ups and downs and twists and turns ahead.
Pharmaceutical Technology
JULY 31, 2024
The US FDA has granted approval for Johnson & Johnson’s (J&J) DARZALEX FASPRO for treating newly diagnosed multiple myeloma (NDMM).
Pharmacy Times
JULY 31, 2024
The findings indicate that zoster vaccine recombinant reduced dementia risk by 17% in an analysis of over 200,000 patients.
Pharmaceutical Technology
JULY 31, 2024
The FDA has set a PDUFA target action date of 30 January 2025 for Vertex’s acute pain treatment therapy that is a non-opioid alternative.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
317 
Let's personalize your content